Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Matthew Coffey
CEO | Chief Executive Officer | - | 11.05.11 |
Kirk Look
DFI | Director of Finance/CFO | - | 01.04.03 |
Thomas Heineman
CTO | Chief Tech/Sci/R&D Officer | - | 01.08.20 |
Jon Patton
IRC | Investor Relations Contact | - | 01.08.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Jonathan Rigby
BRD | Director/Board Member | 56 | 07.09.22 |
Patricia Andrews
BRD | Director/Board Member | 66 | 09.01. |
Bernd Seizinger
BRD | Director/Board Member | 67 | 08.06.15 |
James Parsons
BRD | Director/Board Member | 58 | 16.06.22 |
Angela Holtham
BRD | Director/Board Member | 73 | 18.06.14 |
Matthew Coffey
CEO | Chief Executive Officer | - | 11.05.11 |
Wayne Pisano
CHM | Chairman | 69 | 09.05.13 |
Deborah Brown
BRD | Director/Board Member | - | 02.11.17 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 75 419 768 | 72 478 872 ( 96,10 %) | 0 | 96,10 % |
Unternehmenskontakt
Oncolytics Biotech, Inc.
322–11th Avenue SW Suite 804
T2R 0C5, Calgary
+
http://www.oncolyticsbiotech.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+32,76 % | 49,46 Mrd. | |
+1,34 % | 42,58 Mrd. | |
+49,11 % | 42,49 Mrd. | |
-4,22 % | 29,09 Mrd. | |
+11,66 % | 26,61 Mrd. | |
-22,76 % | 18,64 Mrd. | |
+7,96 % | 13,16 Mrd. | |
+29,98 % | 12,55 Mrd. | |
+24,17 % | 12,1 Mrd. |